SAMHSA (2/10) -- HHS has says that if the SAMHSA is unable to complete rulemaking that allows providers in opioid treatment programs to continue to initiate buprenorphine following a telehealth visit before the May 11 end of the public health emergency, SAMHSA will enact interim measures to bridge any gap that may result after the PHE ends. Cont.
top of page
Search
Recent Posts
See AllSAMHSA [12/19] – SAMHSA has issued a new Practical Guide: Advising People on Using 988 Versus 911 to help in better understanding the...
SAMHSA [12/18] – SAMHSA recently published five documents to promote the integration and advancement of promising practices in SUD...
NIDA [12/17] – After declining significantly during the COVID-19 pandemic, substance use among adolescents has continued to hold steady...
bottom of page
Comments